Form EFFECT Clearside Biomedical,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 16, 2025 |
| Accession Number: | 0001193125-25-319171 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Liberty Partners Releases Institutional Strategy Report Ahead of Potential Anthropic IPO
- Shiba Inu Price Prediction: SHIB Eyes $0.0000062 Breakout as AlphaPepe’s $1 Target Turns $1,000 Into Nearly $34,000
- Monad Price Prediction: $513M Record Day After 98% Gas Cut While Pepeto Quietly Builds Toward 100x
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
